Literature DB >> 10556837

Structure and function of the murine chemokine receptor CXCR3.

B Lu1, A Humbles, D Bota, C Gerard, B Moser, D Soler, A D Luster, N P Gerard.   

Abstract

The gene encoding the murine homologue of human CXCR3 exists in a single copy consisting of two exons with an intron interrupting the coding sequence between nucleotides 10 and 11. The deduced amino acid sequence is 86% identical to the predicted human sequence. Murine CXCR3 mRNA is detectable in bone marrow cells cultured in the presence of IL-2 but not unstimulated cells. It is also detectable at low abundance in normal mouse spleen, lymph node, mammary gland, and thymus. Transfection of murine CXCR3 in murine pre-B lymphocyte line (CXCR3++/L1.2) conferred binding of the ligands IP10, ITAC and Mig with K(D)'s of 1.35 +/- 0.56, 1.41 +/- 0.20, and 11.65 +/- 0.90 nM, respectively. Lower affinity binding was observed for several beta or CC chemokines (eotaxin, MCP-3, MIP3alpha and SLC/6Ckine/Exodus 2). ITAC, IP10 and Mig induced chemotaxis with an order of potency ITAC > IP10 = Mig. The chemokines also increased intracellular calcium concentration and were variably desensitized to repeated agonist stimulation. The hierarchy for cross- desensitization was ITAC > Mig > IP10. Thus, while Mig, ITAC and IP10 all act on the same receptor for binding and agonist stimulation, they may interact with different receptor conformational isoforms to produce divergent responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556837     DOI: 10.1002/(SICI)1521-4141(199911)29:11<3804::AID-IMMU3804>3.0.CO;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Evolving paradigms in the pathogenesis of IBD.

Authors:  Lloyd Mayer
Journal:  J Gastroenterol       Date:  2009-12-04       Impact factor: 7.527

Review 3.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

Review 4.  CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Authors:  Ryuma Tokunaga; Wu Zhang; Madiha Naseem; Alberto Puccini; Martin D Berger; Shivani Soni; Michelle McSkane; Hideo Baba; Heinz-Josef Lenz
Journal:  Cancer Treat Rev       Date:  2017-11-26       Impact factor: 12.111

5.  Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.

Authors:  Eli Maymon; Roberto Romero; Gaurav Bhatti; Piya Chaemsaithong; Nardhy Gomez-Lopez; Bogdan Panaitescu; Noppadol Chaiyasit; Percy Pacora; Zhong Dong; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2018-02-23       Impact factor: 1.901

6.  CXCR3 in T cell function.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

7.  Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.

Authors:  Brian D Thompson; Yongzhu Jin; Kevin H Wu; Richard A Colvin; Andrew D Luster; Lutz Birnbaumer; Mei X Wu
Journal:  J Biol Chem       Date:  2007-02-08       Impact factor: 5.157

8.  Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.

Authors:  Dennis Verzijl; Stefania Storelli; Danny J Scholten; Leontien Bosch; Todd A Reinhart; Daniel N Streblow; Cornelis P Tensen; Carlos P Fitzsimons; Guido J R Zaman; James E Pease; Iwan J P de Esch; Martine J Smit; Rob Leurs
Journal:  J Pharmacol Exp Ther       Date:  2008-02-12       Impact factor: 4.030

9.  Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.

Authors:  Ravindra Uppaluri; Kathleen C F Sheehan; Liqing Wang; Jack D Bui; Joshua J Brotman; Bao Lu; Craig Gerard; Wayne W Hancock; Robert D Schreiber
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

10.  CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.

Authors:  Joshua M Rosenblum; Qi-Wei Zhang; Gerald Siu; Tassie L Collins; Timothy Sullivan; Daniel J Dairaghi; Julio C Medina; Robert L Fairchild
Journal:  Transplantation       Date:  2009-02-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.